Pyrrolidine dithiocarbamate reduced experimental periodontitis

Carmelo Muià1, Emanuela Mazzon, Daniele Maiere

  • 1Department of Clinical and Experimental Medicine and Pharmacology, Torre Biologica, Policlinico Universitario, 98123 Messina, Italy.

Summary

Pyrrolidine dithiocarbamate (PDTC) reduces inflammation and tissue damage in experimental periodontitis. This antioxidant effectively inhibits nuclear factor-kappaB (NF-kappaB) activation, offering a potential therapeutic strategy for this oral inflammatory disease.

Related Concept Videos